Annual Net Income:
-$44.14M-$36.27M(-460.83%)Summary
- As of today, AQST annual net profit is -$44.14 million, with the most recent change of -$36.27 million (-460.83%) on December 31, 2024.
- During the last 3 years, AQST annual net income has risen by +$26.40 million (+37.43%).
- AQST annual net income is now -460.83% below its all-time high of -$7.87 million, reached on December 31, 2023.
Performance
AQST Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Net Income:
-$15.45M-$1.90M(-14.01%)Summary
- As of today, AQST quarterly net profit is -$15.45 million, with the most recent change of -$1.90 million (-14.01%) on September 30, 2025.
- Over the past year, AQST quarterly net income has dropped by -$3.94 million (-34.21%).
- AQST quarterly net income is now -282.77% below its all-time high of $8.45 million, reached on September 30, 2017.
Performance
AQST Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Net Income:
-$68.98M-$3.94M(-6.05%)Summary
- As of today, AQST TTM net profit is -$68.98 million, with the most recent change of -$3.94 million (-6.05%) on September 30, 2025.
- Over the past year, AQST TTM net income has dropped by -$33.79 million (-96.00%).
- AQST TTM net income is now -1086.26% below its all-time high of $6.99 million, reached on September 30, 2017.
Performance
AQST TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
AQST Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -460.8% | -34.2% | -96.0% |
| 3Y3 Years | +37.4% | -23.2% | +2.9% |
| 5Y5 Years | +33.4% | +6.7% | -43.5% |
AQST Net Income Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -460.8% | +37.4% | -291.4% | +32.6% | -776.5% | +2.9% |
| 5Y | 5-Year | -460.8% | +37.4% | -291.4% | +46.6% | -776.5% | +5.5% |
| All-Time | All-Time | -460.8% | +37.4% | -282.8% | +57.7% | -1086.3% | +14.0% |
AQST Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$15.45M(-14.0%) | -$68.98M(-6.1%) |
| Jun 2025 | - | -$13.55M(+40.9%) | -$65.04M(-19.9%) |
| Mar 2025 | - | -$22.93M(-34.4%) | -$54.24M(-22.9%) |
| Dec 2024 | -$44.14M(-460.8%) | -$17.05M(-48.2%) | -$44.14M(-25.4%) |
| Sep 2024 | - | -$11.51M(-319.3%) | -$35.19M(-36.8%) |
| Jun 2024 | - | -$2.75M(+78.6%) | -$25.72M(+10.6%) |
| Mar 2024 | - | -$12.83M(-58.2%) | -$28.77M(-265.5%) |
| Dec 2023 | -$7.87M(+85.5%) | -$8.11M(-298.6%) | -$7.87M(+35.0%) |
| Sep 2023 | - | -$2.04M(+64.9%) | -$12.11M(+46.4%) |
| Jun 2023 | - | -$5.79M(-171.8%) | -$22.61M(+31.7%) |
| Mar 2023 | - | $8.07M(+165.3%) | -$33.12M(+39.1%) |
| Dec 2022 | -$54.41M(+22.9%) | -$12.35M(+1.5%) | -$54.41M(+23.4%) |
| Sep 2022 | - | -$12.54M(+23.1%) | -$71.00M(+2.8%) |
| Jun 2022 | - | -$16.30M(-23.3%) | -$73.02M(-5.7%) |
| Mar 2022 | - | -$13.22M(+54.3%) | -$69.09M(+2.1%) |
| Dec 2021 | -$70.54M | -$28.95M(-98.9%) | -$70.54M(-13.8%) |
| Sep 2021 | - | -$14.55M(-17.7%) | -$61.96M(+3.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$12.37M(+15.7%) | -$63.96M(-18.6%) |
| Mar 2021 | - | -$14.67M(+28.0%) | -$53.92M(+3.3%) |
| Dec 2020 | -$55.78M(+15.8%) | -$20.37M(-23.1%) | -$55.78M(-16.1%) |
| Sep 2020 | - | -$16.55M(-609.1%) | -$48.05M(+3.7%) |
| Jun 2020 | - | -$2.33M(+85.9%) | -$49.91M(+26.7%) |
| Mar 2020 | - | -$16.53M(-30.8%) | -$68.05M(-2.7%) |
| Dec 2019 | -$66.25M(-7.9%) | -$12.64M(+31.4%) | -$66.25M(+1.9%) |
| Sep 2019 | - | -$18.41M(+10.1%) | -$67.55M(-5.3%) |
| Jun 2019 | - | -$20.47M(-39.0%) | -$64.18M(+20.0%) |
| Mar 2019 | - | -$14.73M(-5.6%) | -$80.20M(-30.7%) |
| Dec 2018 | -$61.38M(-586.3%) | -$13.94M(+7.3%) | -$61.38M(-6.8%) |
| Sep 2018 | - | -$15.04M(+58.8%) | -$57.47M(-69.1%) |
| Jun 2018 | - | -$36.49M(-990.3%) | -$33.98M(-1453.9%) |
| Mar 2018 | - | $4.10M(+140.8%) | $2.51M(+182.4%) |
| Dec 2017 | -$8.94M(+6.9%) | -$10.04M(-218.8%) | -$3.05M(-143.6%) |
| Sep 2017 | - | $8.45M(+680.0%) | $6.99M(+580.0%) |
| Mar 2017 | - | -$1.46M | -$1.46M |
| Dec 2016 | -$9.60M | - | - |
FAQ
- What is Aquestive Therapeutics, Inc. annual net profit?
- What is the all-time high annual net income for Aquestive Therapeutics, Inc.?
- What is Aquestive Therapeutics, Inc. annual net income year-on-year change?
- What is Aquestive Therapeutics, Inc. quarterly net profit?
- What is the all-time high quarterly net income for Aquestive Therapeutics, Inc.?
- What is Aquestive Therapeutics, Inc. quarterly net income year-on-year change?
- What is Aquestive Therapeutics, Inc. TTM net profit?
- What is the all-time high TTM net income for Aquestive Therapeutics, Inc.?
- What is Aquestive Therapeutics, Inc. TTM net income year-on-year change?
What is Aquestive Therapeutics, Inc. annual net profit?
The current annual net income of AQST is -$44.14M
What is the all-time high annual net income for Aquestive Therapeutics, Inc.?
Aquestive Therapeutics, Inc. all-time high annual net profit is -$7.87M
What is Aquestive Therapeutics, Inc. annual net income year-on-year change?
Over the past year, AQST annual net profit has changed by -$36.27M (-460.83%)
What is Aquestive Therapeutics, Inc. quarterly net profit?
The current quarterly net income of AQST is -$15.45M
What is the all-time high quarterly net income for Aquestive Therapeutics, Inc.?
Aquestive Therapeutics, Inc. all-time high quarterly net profit is $8.45M
What is Aquestive Therapeutics, Inc. quarterly net income year-on-year change?
Over the past year, AQST quarterly net profit has changed by -$3.94M (-34.21%)
What is Aquestive Therapeutics, Inc. TTM net profit?
The current TTM net income of AQST is -$68.98M
What is the all-time high TTM net income for Aquestive Therapeutics, Inc.?
Aquestive Therapeutics, Inc. all-time high TTM net profit is $6.99M
What is Aquestive Therapeutics, Inc. TTM net income year-on-year change?
Over the past year, AQST TTM net profit has changed by -$33.79M (-96.00%)